  Company profile
Company profileChiasma develops and commercializes oral therapies utilizing its proprietary Transient Permeability Enhancer (TPE®) technology to reduce the burden of chronic injections for people with rare diseases. Chiasma's proprietary TPE® technology is designed to convert select peptide based injectables into oral formulations. By leveraging this technology, patients may be alleviated of the burdens associated with chronic injectable therapies.
AddressBuilding C East Videos about Chiasma Inc | NotesJump to (Finance sites)          ResearchInvestor pageir.chiasmapharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Their Official Profiles  Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk. Take advantage of price swings in strongly trending securities and pump up your portfolio! |
